Solution structure of the proapoptotic molecule BID: A structural basis for apoptotic agonists and antagonists

Cell

Volumn 96, Issue 5, 1999, Pages 625-634

  McDonnell, James M ^a   Fushman, David ^a   Milliman, Curt L ^b   Korsmeyer, Stanley J ^b,c   Cowburn, David ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; PROTEIN BAK; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONFORMATIONAL TRANSITION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN STRUCTURE; REGULATORY MECHANISM; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

EID: 0033525749     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80573-5     Document Type: Article

References (67)

1. Adams, J.M., and Cory, S. (1998). The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322-1326.
2. Antonsson, B., Conti, F., Ciavatta, A., Montessuit, S., Lewis, S., Martinou, I., Bernasconi, L., Bernard, A., Mermod, J.J., Mazzei, G., et al. (1997). Inhibition of Bax channel-forming activity by Bcl-2. Science 277, 370-372.
3. 13C assignments and secondary structure determined with the use of multidimensional double and triple resonance heteronuclear NMR spectroscopy. Biochemistry 33, 2409-2421.
4. Boyd, J.M., Gallo, G.J., Elangovan, B., Houghton, A.B., Malstrom, S., Avery, B.J., Ebb, R.G., Subramanian, T., Chittenden, T., Lutz, R.J., et al. (1995). Bik, a novel death-inducing protein, shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11, 1921-1928.
5. 15N NMR spectroscopy. Biochemistry 34, 16608-16617.
6. Chao, D.T., and Korsmeyer, S.J. (1998). BCL-2 family: regulators of cell death. Annu. Rev. Immunol. 16, 395-419.
7. Cheng, E.H., Kirsch, D.G., Clem, R.J., Ravi, R., Kastan, M.B., Bedi, A., Ueno, K., and Hardwick, J.M. (1997). Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278, 1966-1968.
8. Chinnaiyan, A.M., O'Rourke, K., Lane, B.R., and Dixit, V.M. (1997). Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275, 1122-1126.
9. Chittenden, T., Flemington, C., Houghton, A.B., Ebb, R.G., Gallo, G.J., Elangovan, B., Chinnadurai, G., and Lutz, R.J. (1995). A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14, 5589-5596.
10. Chou, J.J., Li, H., Salvesen, G.S., Yuan, J., and Wagner, G. (1999). Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96, this issue, 615-624.
11. L through caspase interaction. Proc. Natl. Acad. Sci. USA 95, 554-559.
12. 13C resonances of interleukin-1 beta using double- and triple-resonance heteronuclear three-dimensional NMR spectroscopy. Biochemistry 29, 8172-8184.
13. Conradt, B., and Horvitz, H.R. (1998). The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell 93, 519-529.
14. Copie, V., Tomita, Y., Akiyama, S.K., Aota, S., Yamada, K.M., Venable, R.M., Pastor, R.W., Krueger, S., and Torchia, D.A. (1998). Solution structure and dynamics of linked cell attachment modules of mouse fibronectin containing the RGD and synergy regions: comparison with the human fibronectin crystal structure. J. Mol. Biol. 277, 663-682.
15. Darnell, J., Lodish, H., and Baltimore, D. (1990). Molecular Cell Biology (New York: W. H. Freeman and Company).
16. de la Torre, J.G., Navarro, S., Martinez, M.C.L., Diaz, F.G., and Cascales, J.J.L. (1994). HYDRO: a computer program for the prediction of hydrodynamic properties of macromolecules. Biophys. J. 67, 530-531.
17. Dingley, A.J., Mackay, J.P., Chapman, B.E., Morris, M.B., Kuchel, P.W., Hambly, B.D., and King, G.F. (1995). Measuring protein self-association using pulsed-field-gradient NMR spectroscopy: application to myosin light chain 2. J. Biomol. NMR 6, 321-328.
18. Ellis, R.E., Yuan, J.Y., and Horvitz, H.R. (1991). Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7, 663-698.
19. Evans, S.V. (1993). SETOR: hardware lighted three-dimensional solid model representations of macromolecules. J. Mol. Graph. 11, 134-138.
20. 15N relaxation data. J. Biomol. NMR 6, 153-162.
21. Frishman, D., and Argos, P. (1996). Incorporation of non-local inter-actions in protein secondary structure prediction from the amino acid sequence. Protein Eng. 9, 133-142.
22. 15N chemical shift anisotropy from NMR relaxation data. Ubiquitin as a test example. J. Am. Chem. Soc. 120, 7109-7110.
23. 15N relaxation with monomer/dimer equilibration. J. Mol. Biol. 266, 173-194.
24. Geourjon, C., and Deleage, G. (1995). SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput. Appl. Biosci. 11, 681-684.
25. Goping, I.S., Gross, A., Lavoie, J.N., Nguyen, M., Jemmerson, R., Roth, K., Korsmeyer, S.J., and Shore, G.C. (1998). Regulated targeting of BAX to mitochondria. J. Cell Biol. 143, 207-215.
26. Gross, A., Jockel, J., Wei, M.C., and Korsmeyer, S.J. (1998). Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17, 3878-3885.
27. L prevents this release but not TNF-R1/Fas death. J. Biol. Chem. 274, 1156-1163.
28. 15N-enriched proteins. J. Biomol. NMR 3, 185-204.
29. 15N NMR backbone assignments and secondary structure of human interferon-gamma. Biochemistry 31, 8180-8190.
30. Guntert, P., Mumenthaler, C., and Wüthrich, K. (1997). Torsion angle dynamics for NMR structure calculation with the new program DY-ANA. J. Mol. Biol. 273, 283-298.
31. Guntert, P., Braun, W., and Wüthrich, K. (1991 ). Efficient computation of three-dimensional protein structures in solution from nuclear magnetic resonance data using the program DIANA and the supporting programs CALIBA, HABAS, and GLOMSA. J. Mol. Biol. 217, 517-530.
32. L, is a potent death agonist. J. Biol. Chem. 273, 7783-7786.
33. L. EMBO J. 16, 1686-1694.
34. King, R.D., and Sternberg, M.J. (1996). Identification and application of the concepts important for accurate and reliable protein secondary structure prediction. Protein Sci. 5, 2298-2310.
35. Laskowski, R.A., Rullmannn, J.A., MacArthur, M.W., Kaptein, R., and Thornton, J.M. (1996). AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8, 477-486.
36. Lee, L.C., Hunter, J.J., Mujeeb, A., Turck, C., and Parslow, T.G. (1996). Evidence for alpha-helical conformation of an essential N-terminal region in the human Bcl2 protein. J. Biol. Chem. 271, 23284-23288.
37. Li, H., Zhu, H., Xu, C.J., and Yuan, J. (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501.
38. Lipari, G., and Szabo, A. (1982). Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 2. J. Am. Chem. Soc. 104, 4559-4570.
39. Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. (1998). Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481-490.
40. McDonnell, J.M., Fushman, D., Cahill, S.M., Sutton, B.J., and Cowburn, D. (1997). Solution structures of FcεRI α-chain mimics: a β-hairpin peptide and its retroenantiomer. J. Am. Chem. Soc. 119, 5321-5328.
41. McDonnell, J.M., Fushman, D., Cahill, S.M., Zhou, W., Wolven, A., Wilson, C.B., Nelle, T.D., Resh, M.D., Wills, J., and Cowburn, D. (1998). Solution structure and dynamics of the bioactive retroviral M domain from Rous sarcoma virus. J. Mol. Biol 279, 921-928.
42. L, an inhibitor of programmed cell death. Nature 381, 335-341.
43. Murzin, A.G., Brenner, S.E., Hubbard, T., and Chothia, C. (1995). SCOP: a structural classification of proteins database for the investigation of sequences and structures. J. Mol. Biol. 274, 536-540.
44. Nicholls, A., Sharp, K.A., and Honig, B. (1991). Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.
45. O'Connor, L., Strasser, A., O'Reilly, L.A., Hausmann, G., Adams, J.M., Cory, S., and Huang, D.C. (1998). Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17, 384-395.
46. Oltvai, Z.N., Milliman, C.L., and Korsmeyer, S.J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619.
47. Raff, M.C. (1992). Social controls on cell survival and cell death. Nature 356, 397-400.
48. Rost, B., Sander, C., and Schneider, R. (1994). PHD - an automatic mail server for protein secondary structure prediction. Comput. Appl. Biosci. 10, 53-60.
49. L-Bak peptide complex: recognition between regulators of apoptosis. Science 275, 983-986.
50. Schlesinger, P.M., Gross, A., Yin, X.M., Yamamoto, K., Saito, M., Waksman, G., and Korsmeyer, S.J. (1997). Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc. Natl. Acad. Sci. USA 94, 11357-11362.
51. Solovyev, V.V., and Salamov, A.A. (1994). Predicting alpha-helix and beta-strand segments of globular proteins. Comput. Appl. Biosci. 10, 661-669.
52. Strasser, A., Huang, D.C., and Vaux, D.L (1997). The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy. Biochim. Biophys. Acta 1333, F151-F178.
53. Stultz, C.M., White, J.V., and Smith, T.F. (1993). Structural analysis based on state-space modeling. Protein Sci. 2, 305-314.
54. Thompson, C.B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
55. Thompson, J.D., Higgins, D.G., and Gibson, T.J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673-4680.
56. Thornberry, N.A., and Lazebnik, Y. (1998). Caspases: enemies within. Science 281, 1312-1316.
57. Tjandra, N., Garrett, D.S., Gronenborn, A.M., Bax, A., and Clore, G.M. (1997). Defining long range order in NMR structure determination from the dependence of heteronuclear relaxation times on rotational diffusion anisotropy. Nat. Struct. Biol. 4, 443-449.
58. Wang, K., Yin, X.M., Chao, D.T., Milliman, C.L., and Korsmeyer, S.J. (1996). BID: a novel BH3 domain-only death agonist. Genes Dev. 10, 2859-2869.
59. Wang, K., Gross, A., Waksman, G., and Korsmeyer, S.J. (1998). Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing. Mol. Cell. Biol. 18, 6083-6089.
60. Wishart, D., Sykes, B.D., and Richard, F.M. (1992). The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31, 1647-1651.
61. Wolter, K.G., Hsu, Y.T., Smith, C.L., Nechushtan, A., Xi, X.G., and Youle, R.J. (1997). Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139, 1281-1292.
62. Wood, D.E., Thomas, A., Devi, L.A., Berman, Y., Beavis, R.C., Reed, J.C., and Newcomb, E.W. (1998). Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 17, 1069-1078.
63. Wüthrich, K. (1986). NMR of Proteins and Nucleic Acids (New York: John Wiley and Sons).
64. L and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285-291.
65. Yin, X.M., Oltvai, Z.N., and Korsmeyer, S.J. (1994). BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369, 321-323.
66. L. Cell 87, 619-628.
67. L and pro-apoptotic activity. J. Biol. Chem. 272, 24101-24104.